HK Stock Market Move | UNISOUND (09678) rose more than 15% in the morning. It is reported that the new generation of universal baseboard large model U2 will be officially released in June.
EN:
CloudKnow Technology (09678) surged over 15% in the morning, as of the time of writing, it rose by 14.41% to HK$298.6, with a turnover of HK$1.34 billion.
UNISOUND (09678) rose more than 15% in the morning, as of press time, up 14.41% to HK $298.6, with a turnover of HK$ 134 million.
On the news front, recently, according to 36Kr, UNISOUND will officially release the new generation of its general-purpose large-scale model U2 in June. The report states that U2 is seen internally as a key support for the company's entry into the first echelon of domestic general-purpose large models, with its capabilities focusing on knowledge reasoning, instruction following, long context, long-range tasks, coding, and office intelligence.
It is understood that U2 has already demonstrated comprehensive performance comparable to leading global large-scale models in key evaluation areas such as knowledge reasoning, long text understanding, complex instruction following, software engineering, and Agent tool invocation. In instruction following evaluations such as IFBench, U2 performs among the best; in Claw-related evaluations, its Agent and tool invocation capabilities show strong advantages; in hardcore knowledge reasoning and long context tasks like GPQA, U2 also demonstrates the ability to challenge leading models in the industry.
Related Articles

INSILICO (03696) clarification: Currently, there is no definite plan for a second listing.

JINHUI HOLDINGS(00137): Jinhui Shipping first quarter net profit of 4.324 million US dollars decreased by 74.67% year-on-year.

In the first quarter, CSPC Pharma (01093) reported a net profit attributable to shareholders of 860 million yuan, a decrease of 41.8% year-on-year.
INSILICO (03696) clarification: Currently, there is no definite plan for a second listing.

JINHUI HOLDINGS(00137): Jinhui Shipping first quarter net profit of 4.324 million US dollars decreased by 74.67% year-on-year.

In the first quarter, CSPC Pharma (01093) reported a net profit attributable to shareholders of 860 million yuan, a decrease of 41.8% year-on-year.






